{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:12:59Z","timestamp":1788491579885,"version":"build-2803163510"},"reference-count":253,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s43440-025-00694-w","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T09:28:00Z","timestamp":1737365280000},"page":"355-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases"],"prefix":"10.1007","volume":"77","author":[{"given":"Sajad","family":"Abolfazli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Karav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-1444","authenticated-orcid":false,"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"694_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420","volume":"16","author":"CU Correll","year":"2017","unstructured":"Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta\u2010analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16:163\u201380.","journal-title":"World Psychiatry"},{"key":"694_CR2","doi-asserted-by":"crossref","unstructured":"Galiuto L, Locorotondo G. Cardiovascular aging. Integrative Cardiology: A New Therapeutic Vision. 2017:109\u2013\u200920.","DOI":"10.1007\/978-3-319-40010-5_9"},{"key":"694_CR3","doi-asserted-by":"crossref","unstructured":"Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. American College of Cardiology Foundation Washington, DC; 2019. pp. 2529\u201332.","DOI":"10.1016\/j.jacc.2019.10.009"},{"key":"694_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1161\/CIRCRESAHA.116.307547","volume":"118","author":"M Garcia","year":"2016","unstructured":"Garcia M, Mulvagh SL, Bairey Merz CN, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circul Res. 2016;118:1273\u201393.","journal-title":"Circul Res"},{"key":"694_CR5","doi-asserted-by":"publisher","first-page":"e000358","DOI":"10.1136\/openhrt-2015-000358","volume":"3","author":"J Keto","year":"2016","unstructured":"Keto J, Ventola H, Jokelainen J, Linden K, Kein\u00e4nen-Kiukaanniemi S, Timonen M, et al. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart. 2016;3:e000358.","journal-title":"Open Heart"},{"key":"694_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/ijms20030535","volume":"20","author":"C-Y Hou","year":"2019","unstructured":"Hou C-Y, Tain Y-L, Yu H-R, Huang L-T. The effects of resveratrol in the treatment of metabolic syndrome. Int J Mol Sci. 2019;20:535.","journal-title":"Int J Mol Sci"},{"key":"694_CR7","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.3390\/molecules25184282","volume":"25","author":"WH Talib","year":"2020","unstructured":"Talib WH, Alsayed AR, Farhan F, Al Kury LT. Resveratrol and tumor microenvironment: mechanistic basis and therapeutic targets. Molecules. 2020;25:4282.","journal-title":"Molecules"},{"key":"694_CR8","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.3390\/nu13093095","volume":"13","author":"O Vesely","year":"2021","unstructured":"Vesely O, Baldovska S, Kolesarova A. Enhancing bioavailability of nutraceutically used resveratrol and other stilbenoids. Nutrients. 2021;13:3095.","journal-title":"Nutrients"},{"key":"694_CR9","doi-asserted-by":"crossref","unstructured":"Gambini J, Ingl\u00e9s M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L et al. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxidative medicine and cellular longevity. 2015;2015.","DOI":"10.1155\/2015\/837042"},{"key":"694_CR10","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/ijms21062084","volume":"21","author":"A Shaito","year":"2020","unstructured":"Shaito A, Posadino AM, Younes N, Hasan H, Halabi S, Alhababi D, et al. Potential adverse effects of Resveratrol: A literature review. Int J Mol Sci. 2020;21:2084.","journal-title":"Int J Mol Sci"},{"key":"694_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bcp.2019.05.030","volume":"166","author":"P Gresele","year":"2019","unstructured":"Gresele P, Momi S, Guglielmini G. Nitric oxide-enhancing or-releasing agents as antithrombotic drugs. Biochem Pharmacol. 2019;166:300\u201312.","journal-title":"Biochem Pharmacol"},{"key":"694_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829\u201337.","journal-title":"Eur Heart J"},{"key":"694_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.niox.2009.12.004","volume":"22","author":"JL Zweier","year":"2010","unstructured":"Zweier JL, Li H, Samouilov A, Liu X. Mechanisms of Nitrite reduction to nitric oxide in the heart and vessel wall. Nitric Oxide. 2010;22:83\u201390.","journal-title":"Nitric Oxide"},{"key":"694_CR14","doi-asserted-by":"publisher","first-page":"1287505","DOI":"10.3389\/fphar.2023.1287505","volume":"14","author":"S Cotino-N\u00e1jera","year":"2023","unstructured":"Cotino-N\u00e1jera S, Herrera LA, Dom\u00ednguez-G\u00f3mez G, D\u00edaz-Ch\u00e1vez J. Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer. Front Pharmacol. 2023;14:1287505.","journal-title":"Front Pharmacol"},{"key":"694_CR15","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3390\/antiox12122056","volume":"12","author":"L Kursvietiene","year":"2023","unstructured":"Kursvietiene L, Kopustinskiene DM, Staneviciene I, Mongirdiene A, Kubov\u00e1 K, Masteikova R, et al. Anti-cancer properties of resveratrol: a focus on its impact on mitochondrial functions. Antioxidants. 2023;12:2056.","journal-title":"Antioxidants"},{"key":"694_CR16","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1530\/ERC-13-0171","volume":"21","author":"LG Carter","year":"2014","unstructured":"Carter LG, D\u2019Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocrine-related Cancer. 2014;21:R209\u201325.","journal-title":"Endocrine-related Cancer"},{"key":"694_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02280-5","volume":"21","author":"M Alavi","year":"2021","unstructured":"Alavi M, Farkhondeh T, Aschner M, Samarghandian S. Resveratrol mediates its anti-cancer effects by Nrf2 signaling pathway activation. Cancer Cell Int. 2021;21:1\u20139.","journal-title":"Cancer Cell Int"},{"key":"694_CR18","doi-asserted-by":"publisher","first-page":"13611","DOI":"10.3390\/ijms241713611","volume":"24","author":"BK Sinha","year":"2023","unstructured":"Sinha BK. Can nitric oxide-based therapy be improved for the treatment of cancers? A perspective. Int J Mol Sci. 2023;24:13611.","journal-title":"Int J Mol Sci"},{"key":"694_CR19","doi-asserted-by":"publisher","first-page":"Fso44","DOI":"10.4155\/fso.15.44","volume":"1","author":"S Huerta","year":"2015","unstructured":"Huerta S. Nitric oxide for cancer therapy. Future Sci OA. 2015;1:Fso44.","journal-title":"Future Sci OA"},{"key":"694_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1021\/acsbiomaterials.2c01247","volume":"9","author":"W Huang","year":"2022","unstructured":"Huang W, Zhang J, Luo L, Yu Y, Sun T. Nitric oxide and tumors: from small-molecule donor to combination therapy. ACS Biomaterials Sci Eng. 2022;9:139\u201352.","journal-title":"ACS Biomaterials Sci Eng"},{"key":"694_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2019.05.027","volume":"459","author":"RL Flaherty","year":"2019","unstructured":"Flaherty RL, Intabli H, Falcinelli M, Bucca G, Hesketh A, Patel BA, et al. Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase. Cancer Lett. 2019;459:59\u201371.","journal-title":"Cancer Lett"},{"key":"694_CR22","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-22-2791","volume":"29","author":"TP Reddy","year":"2023","unstructured":"Reddy TP, Glynn SA, Billiar TR, Wink DA, Chang JC. Targeting nitric oxide: say NO to Metastasis. Clin Cancer Res. 2023;29:1855\u201368.","journal-title":"Clin Cancer Res"},{"key":"694_CR23","doi-asserted-by":"crossref","unstructured":"Mintz J, Vedenko A, Rosete O, Shah K, Goldstein G, Hare JM et al. Current advances of nitric oxide in Cancer and Anticancer therapeutics. Vaccines. 2021;9.","DOI":"10.3390\/vaccines9020094"},{"key":"694_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1532-5415.2008.02051.x","volume":"57","author":"T Walsh","year":"2009","unstructured":"Walsh T, Donnelly T, Lyons D. Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension, and atherogenesis? J Am Geriatr Soc. 2009;57:140\u20135.","journal-title":"J Am Geriatr Soc"},{"key":"694_CR25","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.3390\/molecules26154533","volume":"26","author":"AM Pourbagher-Shahri","year":"2021","unstructured":"Pourbagher-Shahri AM, Farkhondeh T, Talebi M, Kopustinskiene DM, Samarghandian S, Bernatoniene J. An overview of NO signaling pathways in aging. Molecules. 2021;26:4533.","journal-title":"Molecules"},{"key":"694_CR26","doi-asserted-by":"publisher","first-page":"9932218","DOI":"10.1155\/2021\/9932218","volume":"2021","author":"D-D Zhou","year":"2021","unstructured":"Zhou D-D, Luo M, Huang S-Y, Saimaiti A, Shang A, Gan R-Y, et al. Effects and mechanisms of resveratrol on aging and age-related diseases. Oxidative Med Cell Longev. 2021;2021:9932218.","journal-title":"Oxidative Med Cell Longev"},{"key":"694_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.fct.2013.03.038","volume":"61","author":"KM Kasiotis","year":"2013","unstructured":"Kasiotis KM, Pratsinis H, Kletsas D, Haroutounian SA. Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food Chem Toxicol. 2013;61:112\u201320.","journal-title":"Food Chem Toxicol"},{"key":"694_CR28","doi-asserted-by":"publisher","first-page":"104895","DOI":"10.1016\/j.archger.2022.104895","volume":"107","author":"MA Santos","year":"2023","unstructured":"Santos MA, Franco FN, Caldeira CA, de Ara\u00fajo GR, Vieira A, Chaves MM. Resveratrol has its antioxidant and anti-inflammatory protective mechanisms decreased in aging. Arch Gerontol Geriatr. 2023;107:104895.","journal-title":"Arch Gerontol Geriatr"},{"key":"694_CR29","doi-asserted-by":"publisher","first-page":"1393181","DOI":"10.3389\/fgene.2024.1393181","volume":"15","author":"B Rogina","year":"2024","unstructured":"Rogina B, Tissenbaum HA. SIRT1, resveratrol and aging. Front Genet. 2024;15:1393181.","journal-title":"Front Genet"},{"key":"694_CR30","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.2174\/13816128113196660699","volume":"20","author":"G Testa","year":"2014","unstructured":"Testa G, Biasi F, Poli G, Chiarpotto E. Calorie restriction and dietary restriction mimetics: a strategy for improving healthy aging and longevity. Curr Pharm Design. 2014;20:2950\u201377.","journal-title":"Curr Pharm Design"},{"key":"694_CR31","doi-asserted-by":"crossref","unstructured":"Jenkins KT. Nitrogen Compounds. Hamilton & Hardy\u2019s Industrial Toxicology. 2015:363\u2013\u200970.","DOI":"10.1002\/9781118834015.ch49"},{"key":"694_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","volume":"129","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: beyond eNOS. J Pharmacol Sci. 2015;129:83\u201394.","journal-title":"J Pharmacol Sci"},{"key":"694_CR33","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1089\/ars.2010.3297","volume":"14","author":"RM Santos","year":"2011","unstructured":"Santos RM, Lourenco CF, Pomerleau F, Huettl P, Gerhardt GA, Laranjinha J, et al. Brain nitric oxide inactivation is governed by the vasculature. Antioxid Redox Signal. 2011;14:1011\u201321.","journal-title":"Antioxid Redox Signal"},{"key":"694_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/2045-9912.273957","volume":"9","author":"E Goshi","year":"2019","unstructured":"Goshi E, Zhou G, He Q. Nitric oxide detection methods in vitro and in vivo. Med Gas Res. 2019;9:192\u2013207.","journal-title":"Med Gas Res"},{"key":"694_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.niox.2019.04.005","volume":"88","author":"JJ Poderoso","year":"2019","unstructured":"Poderoso JJ, Helfenberger K, Poderoso C. The effect of nitric oxide on mitochondrial respiration. Nitric Oxide. 2019;88:61\u201372.","journal-title":"Nitric Oxide"},{"key":"694_CR36","first-page":"1246","volume":"2","author":"JP Bola\u00f1os","year":"2010","unstructured":"Bola\u00f1os JP, Heales SJ. Persistent mitochondrial damage by nitric oxide and its derivatives: neuropathological implications. Front Neuroenergetics. 2010;2:1246.","journal-title":"Front Neuroenergetics"},{"key":"694_CR37","doi-asserted-by":"crossref","unstructured":"Traystman R. Cerebral blood Flow Regulation (Carbon Dioxide, Oxygen, and nitric oxide). Primer on Cerebrovascular diseases. Elsevier; 2017. pp. 60\u20137.","DOI":"10.1016\/B978-0-12-803058-5.00011-4"},{"key":"694_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/pr.108.000547","volume":"61","author":"N Toda","year":"2009","unstructured":"Toda N, Ayajiki K, Okamura T. Cerebral blood flow regulation by nitric oxide: recent advances. Pharmacol Rev. 2009;61:62\u201397.","journal-title":"Pharmacol Rev"},{"key":"694_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2014.05.021","volume":"73","author":"CF Louren\u00e7o","year":"2014","unstructured":"Louren\u00e7o CF, Santos RM, Barbosa RM, Cadenas E, Radi R, Laranjinha J. Neurovascular coupling in hippocampus is mediated via diffusion by neuronal-derived nitric oxide. Free Radic Biol Med. 2014;73:421\u20139.","journal-title":"Free Radic Biol Med"},{"key":"694_CR40","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1111\/bph.14800","volume":"177","author":"K Chachlaki","year":"2020","unstructured":"Chachlaki K, Prevot V. Nitric oxide signalling in the brain and its control of bodily functions. Br J Pharmacol. 2020;177:5437\u201358.","journal-title":"Br J Pharmacol"},{"key":"694_CR41","doi-asserted-by":"crossref","unstructured":"Taheri P, Mohammadi F, Nazeri M, Zarei MR, Chamani G, Esfahlani MA et al. Nitric oxide role in anxiety-like behavior, memory and cognitive impairments in animal model of chronic migraine. Heliyon. 2020;6.","DOI":"10.1016\/j.heliyon.2020.e05654"},{"key":"694_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.smrv.2012.01.006","volume":"16","author":"R Cespuglio","year":"2012","unstructured":"Cespuglio R, Amrouni D, Meiller A, Buguet A, Gautier-Sauvign\u00e9 S. Nitric oxide in the regulation of the sleep-wake states. Sleep Med Rev. 2012;16:265\u201379.","journal-title":"Sleep Med Rev"},{"key":"694_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbr.2017.05.010","volume":"330","author":"MP Garc\u00eda-Pardo","year":"2017","unstructured":"Garc\u00eda-Pardo MP, Rodr\u00edguez-Arias M, Mi\u00f1arro J, Aguilar M. Role of nitric oxide pathway in the conditioned rewarding effects of MDMA in mice. Behav Brain Res. 2017;330:75\u20137.","journal-title":"Behav Brain Res"},{"key":"694_CR44","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1038\/npp.2011.62","volume":"36","author":"H Hartung","year":"2011","unstructured":"Hartung H, Threlfell S, Cragg SJ. Nitric oxide donors enhance the frequency dependence of dopamine release in nucleus accumbens. Neuropsychopharmacology. 2011;36:1811\u201322.","journal-title":"Neuropsychopharmacology"},{"key":"694_CR45","first-page":"53","volume":"12","author":"MH Toon","year":"2010","unstructured":"Toon MH, Maybauer MO, Greenwood JE, Maybauer DM, Fraser JF. Management of acute smoke inhalation injury. Crit Care Resusc. 2010;12:53\u201361.","journal-title":"Crit Care Resusc"},{"key":"694_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/14622200210142724","volume":"4","author":"W Vleeming","year":"2002","unstructured":"Vleeming W, Rambali B, Opperhuizen A. The role of nitric oxide in cigarette smoking and nicotine addiction. Nicotine Tob Res. 2002;4:341\u20138.","journal-title":"Nicotine Tob Res"},{"key":"694_CR47","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-06-2149","volume":"67","author":"L Ying","year":"2007","unstructured":"Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 2007;67:1407\u201310.","journal-title":"Cancer Res"},{"key":"694_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/iub.1358","volume":"67","author":"A Szade","year":"2015","unstructured":"Szade A, Grochot-Przeczek A, Florczyk U, Jozkowicz A, Dulak J. Cellular and molecular mechanisms of inflammation\u2010induced angiogenesis. IUBMB Life. 2015;67:145\u201359.","journal-title":"IUBMB Life"},{"key":"694_CR49","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1172\/JCI119868","volume":"100","author":"A Papapetropoulos","year":"1997","unstructured":"Papapetropoulos A, Garc\u00eda-Carde\u00f1a G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Investig. 1997;100:3131\u20139.","journal-title":"J Clin Investig"},{"key":"694_CR50","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/bph.12217","volume":"169","author":"TA Heinrich","year":"2013","unstructured":"Heinrich TA, da Silva RS, Miranda KM, Switzer CH, Wink DA, Fukuto JM. Biological nitric oxide signalling: chemistry and terminology. Br J Pharmacol. 2013;169:1417\u201329.","journal-title":"Br J Pharmacol"},{"key":"694_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41586-019-1584-6","volume":"574","author":"Y Kang","year":"2019","unstructured":"Kang Y, Liu R, Wu J-X, Chen L. Structural insights into the mechanism of human soluble guanylate cyclase. Nature. 2019;574:206\u201310.","journal-title":"Nature"},{"key":"694_CR52","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/sj.ijir.3901208","volume":"16","author":"E Bischoff","year":"2004","unstructured":"Bischoff E. Potency, selectivity, and consequences of nonselectivity of PDE inhibition. Int J Impot Res. 2004;16:S11\u20134.","journal-title":"Int J Impot Res"},{"key":"694_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fphys.2014.00134","volume":"5","author":"NM Rogers","year":"2014","unstructured":"Rogers NM, Seeger F, Garcin ED, Roberts DD, Isenberg JS. Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow. Front Physiol. 2014;5:134.","journal-title":"Front Physiol"},{"key":"694_CR54","first-page":"415","volume-title":"Nitric Oxide signaling in vascular cells is regulated through CD47 by Thrombospondin-1","author":"JS Isenberg","year":"2010","unstructured":"Isenberg JS, Frazier WA, Roberts DD. Nitric Oxide signaling in vascular cells is regulated through CD47 by Thrombospondin-1. Nitric Oxide: Elsevier; 2010. pp. 415\u201340."},{"key":"694_CR55","doi-asserted-by":"crossref","unstructured":"Subelzu N, Bartesaghi S, De Bem A, Radi R. Oxidative inactivation of nitric oxide and peroxynitrite formation in the vasculature. Oxidative stress: Diagnostics, Prevention, and therapy volume 2. ACS; 2015. pp. 91\u2013145.","DOI":"10.1021\/bk-2015-1200.ch004"},{"key":"694_CR56","doi-asserted-by":"publisher","first-page":"2303259","DOI":"10.1002\/advs.202303259","volume":"10","author":"SM Andrabi","year":"2023","unstructured":"Andrabi SM, Sharma NS, Karan A, Shahriar SMS, Cordon B, Ma B, et al. Nitric oxide: physiological functions, delivery, and Biomedical Applications. Adv Sci. 2023;10:2303259.","journal-title":"Adv Sci"},{"key":"694_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0014-5793(80)80091-3","volume":"110","author":"LJ Ignarro","year":"1980","unstructured":"Ignarro LJ, Edwards JC, Gruetter DY, Barry BK, Gruetter CA. Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett. 1980;110:275\u20138.","journal-title":"FEBS Lett"},{"key":"694_CR58","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1161\/CIRCRESAHA.112.268680","volume":"112","author":"HS Chung","year":"2013","unstructured":"Chung HS, Wang S-B, Venkatraman V, Murray CI, Van Eyk JE. Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circul Res. 2013;112:382\u201392.","journal-title":"Circul Res"},{"key":"694_CR59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12013-019-00886-1","volume":"77","author":"AF Vanin","year":"2019","unstructured":"Vanin AF. What is the mechanism of nitric oxide conversion into nitrosonium ions ensuring S-nitrosating processes in living organisms. Cell Biochem Biophys. 2019;77:279\u201392.","journal-title":"Cell Biochem Biophys"},{"key":"694_CR60","doi-asserted-by":"crossref","unstructured":"Radi R. Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine. Proceedings of the National Academy of Sciences. 2018;115:5839-48.","DOI":"10.1073\/pnas.1804932115"},{"key":"694_CR61","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2174\/138945011796150334","volume":"12","author":"S Rocha","year":"2011","unstructured":"Rocha S, Gago B, Pereira B, Barbosa CM, Bartesaghi R, O Lundberg S. Dietary nitrite in nitric oxide biology: a redox interplay with implications for pathophysiology and therapeutics. Curr Drug Targets. 2011;12:1351\u201363.","journal-title":"Curr Drug Targets"},{"key":"694_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/01.RES.0000032114.68919.EF","volume":"91","author":"B Coles","year":"2002","unstructured":"Coles B, Bloodsworth A, Clark SR, Lewis MJ, Cross AR, Freeman BA, et al. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide\u2013derived reactive species in vascular cells. Circul Res. 2002;91:375\u201381.","journal-title":"Circul Res"},{"key":"694_CR63","doi-asserted-by":"publisher","first-page":"35686","DOI":"10.1074\/jbc.M603357200","volume":"281","author":"T Cui","year":"2006","unstructured":"Cui T, Schopfer FJ, Zhang J, Chen K, Ichikawa T, Paul RB, et al. Nitrated fatty acids: endogenous anti-inflammatory signaling mediators. J Biol Chem. 2006;281:35686\u201398.","journal-title":"J Biol Chem"},{"key":"694_CR64","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1073\/pnas.86.9.3375","volume":"86","author":"D Rees","year":"1989","unstructured":"Rees D, Palmer R, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci. 1989;86:3375\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"694_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5487\/TR.2014.30.3.141","volume":"30","author":"K-T Kang","year":"2014","unstructured":"Kang K-T. Endothelium-derived relaxing factors of small resistance arteries in hypertension. Toxicol Res. 2014;30:141\u20138.","journal-title":"Toxicol Res"},{"key":"694_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/ijms20010187","volume":"20","author":"A Daiber","year":"2019","unstructured":"Daiber A, Xia N, Steven S, Oelze M, Hanf A, Kr\u00f6ller-Sch\u00f6n S, et al. New therapeutic implications of endothelial nitric oxide synthase (eNOS) function\/dysfunction in cardiovascular disease. Int J Mol Sci. 2019;20:187.","journal-title":"Int J Mol Sci"},{"key":"694_CR67","doi-asserted-by":"crossref","unstructured":"Pagliaro P, Weber NC, Femmin\u00f2 S, Alloatti G, Penna C. Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies. Basic Res Cardiol. 2024:1\u201336.","DOI":"10.1007\/s00395-024-01061-1"},{"key":"694_CR68","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2017.224","volume":"15","author":"C Farah","year":"2018","unstructured":"Farah C, Michel LY, Balligand J-L. Nitric oxide signalling in cardiovascular health and disease. Nat Reviews Cardiol. 2018;15:292\u2013316.","journal-title":"Nat Reviews Cardiol"},{"key":"694_CR69","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.RES.74.5.970","volume":"74","author":"AM Shah","year":"1994","unstructured":"Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG. 8-bromo-cGMP reduces the myofilament response to Ca2\u2009+\u2009in intact cardiac myocytes. Circul Res. 1994;74:970\u20138.","journal-title":"Circul Res"},{"key":"694_CR70","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1113\/jphysiol.2010.192617","volume":"588","author":"H Wang","year":"2010","unstructured":"Wang H, Viatchenko-Karpinski S, Sun J, Gy\u00f6rke I, Benkusky NA, Kohr MJ, et al. Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S\u2010nitrosylation. J Physiol. 2010;588:2905\u201317.","journal-title":"J Physiol"},{"key":"694_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1126\/science.279.5348.234","volume":"279","author":"L Xu","year":"1998","unstructured":"Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 1998;279:234\u20137.","journal-title":"Science"},{"key":"694_CR72","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/416337a","volume":"416","author":"LA Barouch","year":"2002","unstructured":"Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002;416:337\u20139.","journal-title":"Nature"},{"key":"694_CR73","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1161\/01.RES.87.12.1108","volume":"87","author":"J-N Trochu","year":"2000","unstructured":"Trochu J-N, Bouhour J-B, Kaley G, Hintze TH. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease. Circul Res. 2000;87:1108\u201317.","journal-title":"Circul Res"},{"key":"694_CR74","doi-asserted-by":"publisher","first-page":"ra34074","DOI":"10.1126\/scitranslmed.aac4296","volume":"8","author":"SN Reilly","year":"2016","unstructured":"Reilly SN, Liu X, Carnicer R, Recalde A, Muszkiewicz A, Jayaram R, et al. Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase. Sci Transl Med. 2016;8:ra34074\u201374.","journal-title":"Sci Transl Med"},{"key":"694_CR75","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.RES.77.4.841","volume":"77","author":"P Schwarz","year":"1995","unstructured":"Schwarz P, Diem R, Dun NJ, F\u00f6rstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circul Res. 1995;77:841\u20138.","journal-title":"Circul Res"},{"key":"694_CR76","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1172\/JCI21968","volume":"115","author":"E Takimoto","year":"2005","unstructured":"Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B, et al. Oxidant stress from nitric oxide synthase\u20133 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Investig. 2005;115:1221\u201331.","journal-title":"J Clin Investig"},{"key":"694_CR77","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(04)16048-0","volume":"363","author":"T Damy","year":"2004","unstructured":"Damy T, Ratajczak P, Shah AM, Camors E, Marty I, Hasenfuss G, et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet. 2004;363:1365\u20137.","journal-title":"Lancet"},{"key":"694_CR78","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1161\/01.CIR.93.6.1087","volume":"93","author":"GA Haywood","year":"1996","unstructured":"Haywood GA, Tsao PS, Von Der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087\u201394.","journal-title":"Circulation"},{"key":"694_CR79","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1161\/CIRCULATIONAHA.105.539437","volume":"112","author":"D Dawson","year":"2005","unstructured":"Dawson D, Lygate CA, Zhang M-H, Hulbert K, Neubauer S, Casadei B. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation. 2005;112:3729\u201337.","journal-title":"Circulation"},{"key":"694_CR80","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1161\/CIRCULATIONAHA.107.741702","volume":"117","author":"X Loyer","year":"2008","unstructured":"Loyer X, G\u00f3mez AM, Milliez P, Fernandez-Velasco M, Vangheluwe P, Vinet L, et al. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling. Circulation. 2008;117:3187\u201398.","journal-title":"Circulation"},{"key":"694_CR81","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/01.CIR.101.4.439","volume":"101","author":"N Sasaki","year":"2000","unstructured":"Sasaki N, Sato T, Ohler A, O\u2019Rourke B, Marb\u00e1n E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 2000;101:439\u201345.","journal-title":"Circulation"},{"key":"694_CR82","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1084\/jem.20070198","volume":"204","author":"S Shiva","year":"2007","unstructured":"Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, et al. Nitrite augments tolerance to ischemia\/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med. 2007;204:2089\u2013102.","journal-title":"J Exp Med"},{"key":"694_CR83","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nm.3212","volume":"19","author":"ET Chouchani","year":"2013","unstructured":"Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med. 2013;19:753\u20139.","journal-title":"Nat Med"},{"key":"694_CR84","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1042\/BJ20051435","volume":"394","author":"LS Burwell","year":"2006","unstructured":"Burwell LS, Nadtochiy SM, Tompkins AJ, Young S, Brookes PS. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J. 2006;394:627\u201334.","journal-title":"Biochem J"},{"key":"694_CR85","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/joim.12441","volume":"279","author":"S Omar","year":"2016","unstructured":"Omar S, Webb A, Lundberg J, Weitzberg E. Therapeutic effects of inorganic nitrate and nitrite in cardiovascular and metabolic diseases. J Intern Med. 2016;279:315\u201336.","journal-title":"J Intern Med"},{"key":"694_CR86","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/15230860050192161","volume":"2","author":"FS Laroux","year":"2000","unstructured":"Laroux FS, Lefer DJ, Kawachi S, Scalia R, Cockrell AS, Gray L, et al. Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal. 2000;2:391\u20136.","journal-title":"Antioxid Redox Signal"},{"key":"694_CR87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1538-7836.2009.03424.x","volume":"7","author":"W Sessa","year":"2009","unstructured":"Sessa W. Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Haemost. 2009;7:35\u20137.","journal-title":"J Thromb Haemost"},{"key":"694_CR88","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mvr.2008.10.005","volume":"77","author":"A Boueiz","year":"2009","unstructured":"Boueiz A, Hassoun PM. Regulation of endothelial barrier function by reactive oxygen and nitrogen species. Microvasc Res. 2009;77:26\u201334.","journal-title":"Microvasc Res"},{"key":"694_CR89","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1113\/expphysiol.1997.sp004032","volume":"82","author":"KE McQUAID","year":"1997","unstructured":"McQUAID KE, Keenan AK. Endothelial barrier dysfunction and oxidative stress: roles for nitric oxide? Experimental Physiology: Translation Integr. 1997;82:369\u201376.","journal-title":"Experimental Physiology: Translation Integr"},{"key":"694_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1472-8206.2003.00124.x","volume":"17","author":"P Vallance","year":"2003","unstructured":"Vallance P. Nitric oxide: therapeutic opportunities. Fundam Clin Pharmacol. 2003;17:1\u201310.","journal-title":"Fundam Clin Pharmacol"},{"key":"694_CR91","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.vh.2016.09.001","volume":"103","author":"K Gulati","year":"2017","unstructured":"Gulati K, Rai N, Ray A. Nitric oxide and anxiety. Vitam Horm. 2017;103:169\u201392.","journal-title":"Vitam Horm"},{"key":"694_CR92","doi-asserted-by":"publisher","first-page":"2001550","DOI":"10.1002\/adhm.202001550","volume":"10","author":"G Jin","year":"2021","unstructured":"Jin G, Gao Z, Liu Y, Zhao J, Ou H, Xu F, et al. Polymeric nitric oxide delivery nanoplatforms for treating cancer, cardiovascular diseases, and infection. Adv Healthc Mater. 2021;10:2001550.","journal-title":"Adv Healthc Mater"},{"key":"694_CR93","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s12272-009-1801-1","volume":"32","author":"C Napoli","year":"2009","unstructured":"Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res. 2009;32:1103\u20138.","journal-title":"Arch Pharm Res"},{"key":"694_CR94","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.jacc.2017.09.1064","volume":"70","author":"S Divakaran","year":"2017","unstructured":"Divakaran S, Loscalzo J. The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics. J Am Coll Cardiol. 2017;70:2393\u2013410.","journal-title":"J Am Coll Cardiol"},{"key":"694_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MCO.0b013e328332f99d","volume":"13","author":"YC Luiking","year":"2010","unstructured":"Luiking YC, Engelen MP, Deutz NE. Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care. 2010;13:97.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"694_CR96","doi-asserted-by":"crossref","unstructured":"Wu G, Meininger CJ, McNeal CJ, Bazer FW, Rhoads JM. Role of L-arginine in nitric oxide synthesis and health in humans. Amino Acids in Nutrition and Health: Amino Acids in Gene Expression, Metabolic Regulation, and Exercising Performance. 2021:167\u2013\u200987.","DOI":"10.1007\/978-3-030-74180-8_10"},{"key":"694_CR97","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1160\/TH14-11-0937","volume":"114","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GYH, Muntner P, et al. Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2015;114:546\u201357.","journal-title":"Thromb Haemost"},{"key":"694_CR98","doi-asserted-by":"crossref","unstructured":"Sahebkar A, Kiaie N, Gorabi AM, Mannarino MR, Bainaconi V, Jamialahmadi T et al. A comprehensive review on the lipid and pleiotropic effects of pitavastatin. Prog Lipid Res. 2021;84.","DOI":"10.1016\/j.plipres.2021.101127"},{"key":"694_CR99","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phrs.2018.08.014","volume":"135","author":"A Bahrami","year":"2018","unstructured":"Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A. Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res. 2018;135:230\u20138.","journal-title":"Pharmacol Res"},{"key":"694_CR100","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","volume":"12","author":"H Mollazadeh","year":"2021","unstructured":"Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021;12:237\u201351.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"694_CR101","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2016.07.897","volume":"253","author":"P Chru\u015bciel","year":"2016","unstructured":"Chru\u015bciel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194\u2013208.","journal-title":"Atherosclerosis"},{"key":"694_CR102","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1160\/th15-08-0620","volume":"115","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GYH, et al. The impact of statin therapy on plasma levels of Von Willebrand factor antigen: systematic review and meta-analysis of Randomised placebo-controlled trials. Thromb Haemost. 2016;115:520\u201332.","journal-title":"Thromb Haemost"},{"key":"694_CR103","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"SMR Parizadeh","year":"2011","unstructured":"Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46:333\u201340.","journal-title":"Lipids"},{"key":"694_CR104","doi-asserted-by":"crossref","unstructured":"Serban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GYH et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep. 2015;5.","DOI":"10.1038\/srep09902"},{"key":"694_CR105","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/jcm8122051","volume":"8","author":"AM Gorabi","year":"2019","unstructured":"Gorabi AM, Kiaie N, Hajighasemi S, Banach M, Penson PE, Jamialahmadi T, et al. Statin-induced nitric oxide signaling: mechanisms and therapeutic implications. J Clin Med. 2019;8:2051.","journal-title":"J Clin Med"},{"key":"694_CR106","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/01.RES.0000196564.18314.23","volume":"97","author":"Y Rikitake","year":"2005","unstructured":"Rikitake Y, Liao JK. Rho GTPases, statins, and nitric oxide. Circul Res. 2005;97:1232\u20135.","journal-title":"Circul Res"},{"key":"694_CR107","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/01.CIR.0000111128.83347.7A","volume":"109","author":"GA Plenz","year":"2004","unstructured":"Plenz GA, Hofnagel O, Robenek H. Differential modulation of caveolin-1 expression in cells of the vasculature by statins. Circulation. 2004;109:e7\u20138.","journal-title":"Circulation"},{"key":"694_CR108","doi-asserted-by":"publisher","first-page":"H251","DOI":"10.1152\/ajpheart.00195.2009","volume":"298","author":"CY Ivashchenko","year":"2010","unstructured":"Ivashchenko CY, Bradley BT, Ao Z, Leiper J, Vallance P, Johns DG. Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and-2. Am J Physiol Heart Circ Physiol. 2010;298:H251\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"694_CR109","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161212799504803","volume":"18","author":"AS Antonopoulos","year":"2012","unstructured":"Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Design. 2012;18:1519.","journal-title":"Curr Pharm Design"},{"key":"694_CR110","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.2174\/138161210793797870","volume":"16","author":"U Nussinovitch","year":"2010","unstructured":"Nussinovitch U, Freire de Carvalho J, Pereira MR, Shoenfeld Y. Glucocorticoids and the cardiovascular system: state of the art. Curr Pharm Design. 2010;16:3574\u201385.","journal-title":"Curr Pharm Design"},{"key":"694_CR111","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/cells8101227","volume":"8","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang T-N, Knight JK, Goodwin JE. The glucocorticoid receptor in cardiovascular health and disease. Cells. 2019;8:1227.","journal-title":"Cells"},{"key":"694_CR112","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","volume":"237","author":"H Li","year":"2014","unstructured":"Li H, Horke S, F\u00f6rstermann U. Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis. 2014;237:208\u201319.","journal-title":"Atherosclerosis"},{"key":"694_CR113","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.coph.2013.01.006","volume":"13","author":"H Li","year":"2013","unstructured":"Li H, F\u00f6rstermann U. Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease. Curr Opin Pharmacol. 2013;13:161\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"694_CR114","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.redox.2020.101506","volume":"34","author":"A Daiber","year":"2020","unstructured":"Daiber A, Kr\u00f6ller-Sch\u00f6n S, Oelze M, Hahad O, Li H, Schulz R, et al. Oxidative stress and inflammation contribute to traffic noise-induced vascular and cerebral dysfunction via uncoupling of nitric oxide synthases. Redox Biol. 2020;34:101506.","journal-title":"Redox Biol"},{"key":"694_CR115","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.2174\/13816128113196660749","volume":"20","author":"H Li","year":"2014","unstructured":"Li H, Forstermann U. Pharmacological prevention of eNOS uncoupling. Curr Pharm Design. 2014;20:3595\u2013606.","journal-title":"Curr Pharm Design"},{"key":"694_CR116","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","volume":"125","author":"C Cunnington","year":"2012","unstructured":"Cunnington C, Van Assche T, Shirodaria C, Kylintireas I, Lindsay AC, Lee JM, et al. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation. 2012;125:1356\u201366.","journal-title":"Circulation"},{"key":"694_CR117","doi-asserted-by":"crossref","unstructured":"Li Z, Wang L, Ren Y, Huang Y, Liu W, Lv Z. Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases. Cell Death Discov. 2022.","DOI":"10.1038\/s41420-022-01200-4"},{"key":"694_CR118","doi-asserted-by":"crossref","unstructured":"Yang J, Gonon AT, Sj\u00f6quist P-O, Lundberg JO, Pernow J. Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. Proceedings of the National Academy of Sciences. 2013;110:15049-54.","DOI":"10.1073\/pnas.1307058110"},{"key":"694_CR119","doi-asserted-by":"crossref","unstructured":"Gonon AT, Jung C, Katz A, Westerblad H, Shemyakin A, Sj\u00f6quist P-O et al. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. 2012.","DOI":"10.1371\/journal.pone.0042038"},{"key":"694_CR120","doi-asserted-by":"publisher","first-page":"H379","DOI":"10.1152\/ajpheart.00766.2011","volume":"302","author":"A Stangherlin","year":"2012","unstructured":"Stangherlin A, Zaccolo M. Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system. Am J Physiol Heart Circ Physiol. 2012;302:H379\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"694_CR121","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1111\/bph.14920","volume":"177","author":"N Tzoumas","year":"2020","unstructured":"Tzoumas N, Farrah TE, Dhaun N, Webb DJ. Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease. Br J Pharmacol. 2020;177:5467\u201388.","journal-title":"Br J Pharmacol"},{"key":"694_CR122","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/bph.13749","volume":"175","author":"S Korkmaz-Ic\u00f6z","year":"2018","unstructured":"Korkmaz-Ic\u00f6z S, Radovits T, Szab\u00f3 G. Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia\/reperfusion injury and for treating heart failure. Br J Pharmacol. 2018;175:223\u201331.","journal-title":"Br J Pharmacol"},{"key":"694_CR123","volume-title":"PDE5 inhibitors","author":"A Dhaliwal","year":"2022","unstructured":"Dhaliwal A, Gupta M. PDE5 inhibitors. StatPearls [Internet]: StatPearls Publishing; 2022."},{"key":"694_CR124","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cardiores.2006.06.030","volume":"73","author":"LJ Ignarro","year":"2007","unstructured":"Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovascular Res. 2007;73:326\u201340.","journal-title":"Cardiovascular Res"},{"key":"694_CR125","doi-asserted-by":"crossref","unstructured":"Yamagata K. Prevention of vascular endothelial dysfunction by polyphenols: role in cardiovascular disease prevention. Phytopharmaceuticals: Potential Therapeutic Appl. 2021:223\u201346.","DOI":"10.1002\/9781119682059.ch11"},{"key":"694_CR126","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3109\/10715762.2012.694428","volume":"46","author":"C Laurent","year":"2012","unstructured":"Laurent C, Chabi B, Fouret G, Py G, Sairafi B, Elong C, et al. Polyphenols decreased liver NADPH oxidase activity, increased muscle mitochondrial biogenesis and decreased gastrocnemius age-dependent autophagy in aged rats. Free Radic Res. 2012;46:1140\u20139.","journal-title":"Free Radic Res"},{"key":"694_CR127","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.3390\/molecules25153469","volume":"25","author":"M Cebova","year":"2020","unstructured":"Cebova M, Pechanova O. Protective effects of polyphenols against ischemia\/reperfusion injury. Molecules. 2020;25:3469.","journal-title":"Molecules"},{"key":"694_CR128","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejphar.2004.07.034","volume":"500","author":"J-C Stoclet","year":"2004","unstructured":"Stoclet J-C, Chataigneau T, Ndiaye M, Oak M-H, El Bedoui J, Chataigneau M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500:299\u2013313.","journal-title":"Eur J Pharmacol"},{"key":"694_CR129","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/antiox12010147","volume":"12","author":"G Serreli","year":"2023","unstructured":"Serreli G, Deiana M. Role of Dietary polyphenols in the activity and expression of nitric oxide synthases: a review. Antioxidants. 2023;12:147.","journal-title":"Antioxidants"},{"key":"694_CR130","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.bbadis.2018.08.019","volume":"1865","author":"V Adams","year":"2019","unstructured":"Adams V, Linke A. Impact of exercise training on cardiovascular disease and risk. Biochim et Biophys Acta (BBA)-Molecular Basis Disease. 2019;1865:728\u201334.","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Basis Disease"},{"key":"694_CR131","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40279-014-0149-y","volume":"44","author":"AM Jones","year":"2014","unstructured":"Jones AM. Dietary nitrate supplementation and exercise performance. Sports Med. 2014;44:35\u201345.","journal-title":"Sports Med"},{"key":"694_CR132","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1039\/c9mt00264b","volume":"12","author":"Y He","year":"2020","unstructured":"He Y, Fu Y, Xi M, Zheng H, Zhang Y, Liu Y, et al. Zn2\u2009+\u2009and mPTP mediate resveratrol-induced myocardial protection from endoplasmic reticulum stress. Metallomics. 2020;12:290\u2013300.","journal-title":"Metallomics"},{"key":"694_CR133","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.redox.2018.10.021","volume":"20","author":"C Chen","year":"2019","unstructured":"Chen C, Zou L-X, Lin Q-Y, Yan X, Bi H-L, Xie X, et al. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biol. 2019;20:390\u2013401.","journal-title":"Redox Biol"},{"key":"694_CR134","doi-asserted-by":"publisher","first-page":"174380","DOI":"10.1016\/j.ejphar.2021.174380","volume":"908","author":"M Omraninava","year":"2021","unstructured":"Omraninava M, Razi B, Aslani S, Imani D, Jamialahmadi T, Sahebkar A. Effect of resveratrol on inflammatory cytokines: a meta-analysis of randomized controlled trials. Eur J Pharmacol. 2021;908:174380.","journal-title":"Eur J Pharmacol"},{"key":"694_CR135","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1139\/cjpp-2018-0544","volume":"97","author":"XL Louis","year":"2019","unstructured":"Louis XL, Raj P, Chan L, Zieroth S, Netticadan T, Wigle JT. Are the cardioprotective effects of the phytoestrogen resveratrol sex-dependent? Can J Physiol Pharmacol. 2019;97:503\u201314.","journal-title":"Can J Physiol Pharmacol"},{"key":"694_CR136","doi-asserted-by":"publisher","first-page":"20","DOI":"10.26650\/IstanbulJPharm.2022.979195","volume":"52","author":"NB Bal","year":"2022","unstructured":"Bal NB, Han S, Usanmaz S, Uluda\u011f O, Y\u0131lmaz ED. Sex-dependent effects of resveratrol and regular exercise on markers related to cellular stress in the hearts and kidneys of rats. \u0130stanbul J Pharm. 2022;52:20\u201330.","journal-title":"\u0130stanbul J Pharm"},{"key":"694_CR137","doi-asserted-by":"crossref","unstructured":"Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. American journal of physiology-Heart and circulatory physiology; 2011.","DOI":"10.1152\/ajpheart.00554.2011"},{"key":"694_CR138","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.bbrc.2003.08.105","volume":"309","author":"SS Leonard","year":"2003","unstructured":"Leonard SS, Xia C, Jiang B-H, Stinefelt B, Klandorf H, Harris GK, et al. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun. 2003;309:1017\u201326.","journal-title":"Biochem Biophys Res Commun"},{"key":"694_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.09.016","volume":"101","author":"L Yang","year":"2016","unstructured":"Yang L, Zhang Y, Zhu M, Zhang Q, Wang X, Wang Y, et al. Resveratrol attenuates myocardial ischemia\/reperfusion injury through up-regulation of vascular endothelial growth factor B. Free Radic Biol Med. 2016;101:1\u20139.","journal-title":"Free Radic Biol Med"},{"key":"694_CR140","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.freeradbiomed.2004.10.020","volume":"38","author":"H-L Li","year":"2005","unstructured":"Li H-L, Wang A-B, Huang Y, Liu D-P, Wei C, Williams GM, et al. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med. 2005;38:243\u201357.","journal-title":"Free Radic Biol Med"},{"key":"694_CR141","first-page":"111","volume":"60","author":"G Spanier","year":"2009","unstructured":"Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, et al. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol. 2009;60:111\u20136.","journal-title":"J Physiol Pharmacol"},{"key":"694_CR142","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mce.2015.05.034","volume":"412","author":"S Guo","year":"2015","unstructured":"Guo S, Yao Q, Ke Z, Chen H, Wu J, Liu C. Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol Cell Endocrinol. 2015;412:85\u201394.","journal-title":"Mol Cell Endocrinol"},{"key":"694_CR143","doi-asserted-by":"crossref","unstructured":"Rius-P\u00e9rez S, Torres-Cuevas I, Mill\u00e1n I, Ortega \u00c1L, P\u00e9rez S. PGC-1\u03b1, inflammation, and oxidative stress: an integrative view in metabolism. Oxidative medicine and cellular longevity. 2020;2020.","DOI":"10.1155\/2020\/1452696"},{"key":"694_CR144","doi-asserted-by":"crossref","unstructured":"Ma S, Feng J, Zhang R, Chen J, Han D, Li X et al. SIRT1 activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice. Oxidative medicine and cellular longevity. 2017;2017.","DOI":"10.1155\/2017\/4602715"},{"key":"694_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40104-018-0248-y","volume":"9","author":"Q Meng","year":"2018","unstructured":"Meng Q, Guo T, Li G, Sun S, He S, Cheng B, et al. Dietary resveratrol improves antioxidant status of sows and piglets and regulates antioxidant gene expression in placenta by Keap1-Nrf2 pathway and Sirt1. J Anim Sci Biotechnol. 2018;9:1\u201313.","journal-title":"J Anim Sci Biotechnol"},{"key":"694_CR146","doi-asserted-by":"crossref","unstructured":"Zhuang Y, Wu H, Wang X, He J, He S, Yin Y. Resveratrol attenuates oxidative stress-induced intestinal barrier injury through PI3K\/Akt-mediated Nrf2 signaling pathway. Oxidative medicine and cellular longevity. 2019;2019.","DOI":"10.1155\/2019\/7591840"},{"key":"694_CR147","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvq376","volume":"90","author":"A Planavila","year":"2011","unstructured":"Planavila A, Iglesias R, Giralt M, Villarroya F. Sirt1 acts in association with PPAR\u03b1 to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovascular Res. 2011;90:276\u201384.","journal-title":"Cardiovascular Res"},{"key":"694_CR148","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.phrs.2018.11.041","volume":"139","author":"W San Cheang","year":"2019","unstructured":"San Cheang W, Wong WT, Wang L, Cheng CK, Lau CW, Ma RCW, et al. Resveratrol ameliorates endothelial dysfunction in diabetic and obese mice through sirtuin 1 and peroxisome proliferator-activated receptor \u03b4. Pharmacol Res. 2019;139:384\u201394.","journal-title":"Pharmacol Res"},{"key":"694_CR149","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/abbs\/gmu135","volume":"47","author":"C Ma","year":"2015","unstructured":"Ma C, Wang Y, Dong L, Li M, Cai W. Anti-inflammatory effect of resveratrol through the suppression of NF-\u03baB and JAK\/STAT signaling pathways. Acta Biochim Biophys Sin. 2015;47:207\u201313.","journal-title":"Acta Biochim Biophys Sin"},{"key":"694_CR150","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.freeradbiomed.2018.10.432","volume":"130","author":"DML Pinheiro","year":"2019","unstructured":"Pinheiro DML, de Oliveira AHS, Coutinho LG, Fontes FL, de Medeiros Oliveira RK, Oliveira TT, et al. Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation. Free Radic Biol Med. 2019;130:8\u201322.","journal-title":"Free Radic Biol Med"},{"key":"694_CR151","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1159\/000358696","volume":"33","author":"Y Yang","year":"2014","unstructured":"Yang Y, Li S, Yang Q, Shi Y, Zheng M, Liu Y, et al. Resveratrol reduces the proinflammatory effects and lipopolysaccharide-induced expression of HMGB1 and TLR4 in RAW264. 7 cells. Cell Physiol Biochem. 2014;33:1283\u201392.","journal-title":"Cell Physiol Biochem"},{"key":"694_CR152","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2174\/1389450120666190222181506","volume":"20","author":"A Narayanankutty","year":"2019","unstructured":"Narayanankutty A. Toll-like receptors as a novel therapeutic target for natural products against chronic diseases. Curr Drug Targets. 2019;20:1068\u201380.","journal-title":"Curr Drug Targets"},{"key":"694_CR153","doi-asserted-by":"crossref","unstructured":"Xu A, Deng F, Chen Y, Kong Y, Pan L, Liao Q, et al. NF-\u03baB pathwayactivation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity. Biomed Pharmacother. 2020 Oct;130:110525. doi: 10.1016\/j.biopha.2020.110525. Epub 2020 Jul 20. PMID: 32702633.","DOI":"10.1016\/j.biopha.2020.110525"},{"key":"694_CR154","doi-asserted-by":"crossref","unstructured":"Hu M, Yuan X, Liu Y, Tang S, Miao J, Zhou Q, Chen S. IL-1\u03b2-induced NF-\u03baB activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1. Biomed Pharmacother. 2017 Nov;95:1147-1155. doi: 10.1016\/j.biopha.2017.08.120. Epub 2017 Oct 6. PMID: 28926924","DOI":"10.1016\/j.biopha.2017.08.120"},{"key":"694_CR155","doi-asserted-by":"crossref","unstructured":"Cheng W, Cui C, Liu G, Ye C, Shao F, Bagchi AK, Mehta JL, Wang X. NF-\u03baB, A Potential Therapeutic Target in Cardiovascular Diseases. Cardiovasc Drugs Ther. 2023 Jun;37(3):571-584. doi: 10.1007\/s10557-022-07362-8. Epub 2022 Jul 7. PMID: 35796905.","DOI":"10.1007\/s10557-022-07362-8"},{"key":"694_CR156","doi-asserted-by":"publisher","first-page":"030006052094513","DOI":"10.1177\/0300060520945131","volume":"48","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liu H, Tang W, Qiu Q, Peng J. Resveratrol prevents TNF-\u03b1-induced VCAM-1 and ICAM-1 upregulation in endothelial progenitor cells via reduction of NF-\u03ba B activation. J Int Med Res. 2020;48:0300060520945131.","journal-title":"J Int Med Res"},{"key":"694_CR157","doi-asserted-by":"crossref","unstructured":"Seo Y, Park J, Choi W, Ju Son D, Sung Kim Y, Kim M-K et al. Antiatherogenic effect of resveratrol attributed to decreased expression of ICAM-1 (Intercellular adhesion Molecule-1) mechanistic link from focal adhesion to monocyte adhesion. Arteriosclerosis, thrombosis, and vascular biology. 2019;39:675\u2013\u200984.","DOI":"10.1161\/ATVBAHA.118.312201"},{"key":"694_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1823-z","volume":"17","author":"J Schwager","year":"2017","unstructured":"Schwager J, Richard N, Widmer F, Raederstorff D. Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells. BMC Complement Altern Med. 2017;17:1\u201312.","journal-title":"BMC Complement Altern Med"},{"key":"694_CR159","doi-asserted-by":"publisher","first-page":"22727","DOI":"10.1074\/jbc.M314302200","volume":"279","author":"LM Szewczuk","year":"2004","unstructured":"Szewczuk LM, Forti L, Stivala LA, Penning TM. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem. 2004;279:22727\u201337.","journal-title":"J Biol Chem"},{"key":"694_CR160","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3892\/ijmm.2014.1680","volume":"33","author":"W Dong","year":"2014","unstructured":"Dong W, Wang X, Bi S, Pan Z, Liu S, Yu H, et al. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. Int J Mol Med. 2014;33:1161\u20138.","journal-title":"Int J Mol Med"},{"key":"694_CR161","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2017.03.003","volume":"132","author":"C-M Yang","year":"2017","unstructured":"Yang C-M, Chen Y-W, Chi P-L, Lin C-C, Hsiao L-D. Resveratrol inhibits BK-induced COX-2 transcription by suppressing acetylation of AP-1 and NF-\u03baB in human rheumatoid arthritis synovial fibroblasts. Biochem Pharmacol. 2017;132:77\u201391.","journal-title":"Biochem Pharmacol"},{"key":"694_CR162","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00011-017-1072-0","volume":"66","author":"AK Singh","year":"2017","unstructured":"Singh AK, Vinayak M. Resveratrol alleviates inflammatory hyperalgesia by modulation of reactive oxygen species (ROS), antioxidant enzymes and ERK activation. Inflamm Res. 2017;66:911\u201321.","journal-title":"Inflamm Res"},{"key":"694_CR163","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bbamcr.2006.12.002","volume":"1773","author":"K Kondoh","year":"2007","unstructured":"Kondoh K, Nishida E. Regulation of MAP kinases by MAP kinase phosphatases. Biochim et Biophys Acta (BBA)-Molecular Cell Res. 2007;1773:1227\u201337.","journal-title":"Biochim et Biophys Acta (BBA)-Molecular Cell Res"},{"key":"694_CR164","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11684-018-0655-7","volume":"12","author":"J Song","year":"2018","unstructured":"Song J, Huang Y, Zheng W, Yan J, Cheng M, Zhao R, et al. Resveratrol reduces intracellular reactive oxygen species levels by inducing autophagy through the AMPK-mTOR pathway. Front Med. 2018;12:697\u2013706.","journal-title":"Front Med"},{"key":"694_CR165","doi-asserted-by":"publisher","first-page":"104626","DOI":"10.1016\/j.phrs.2019.104626","volume":"152","author":"A Sanches-Silva","year":"2020","unstructured":"Sanches-Silva A, Testai L, Nabavi SF, Battino M, Devi KP, Tejada S, et al. Therapeutic potential of polyphenols in cardiovascular diseases: regulation of mTOR signaling pathway. Pharmacol Res. 2020;152:104626.","journal-title":"Pharmacol Res"},{"key":"694_CR166","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/abbs\/gmab012","volume":"53","author":"Y Hu","year":"2021","unstructured":"Hu Y, Pan H, Peng J, He J, Tang M, Yan S, et al. Resveratrol inhibits necroptosis by mediating the TNF-\u03b1\/RIP1\/RIP3\/MLKL pathway in myocardial hypoxia\/reoxygenation injury. Acta Biochim Biophys Sin. 2021;53:430\u20137.","journal-title":"Acta Biochim Biophys Sin"},{"key":"694_CR167","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.111.01009","volume":"62","author":"A Carrizzo","year":"2013","unstructured":"Carrizzo A, Puca A, Damato A, Marino M, Franco E, Pompeo F, et al. Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension. 2013;62:359\u201366.","journal-title":"Hypertension"},{"key":"694_CR168","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924\u201367.","journal-title":"Pharmacol Rev"},{"key":"694_CR169","doi-asserted-by":"publisher","first-page":"16102","DOI":"10.3390\/molecules191016102","volume":"19","author":"N Xia","year":"2014","unstructured":"Xia N, F\u00f6rstermann U, Li H. Resveratrol and endothelial nitric oxide. Molecules. 2014;19:16102\u201321.","journal-title":"Molecules"},{"key":"694_CR170","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1124\/jpet.110.168724","volume":"335","author":"N Xia","year":"2010","unstructured":"Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, et al. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther. 2010;335:149\u201354.","journal-title":"J Pharmacol Exp Ther"},{"key":"694_CR171","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.niox.2013.04.001","volume":"32","author":"N Xia","year":"2013","unstructured":"Xia N, Strand S, Schlufter F, Siuda D, Reifenberg G, Kleinert H, et al. Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. Nitric Oxide. 2013;32:29\u201335.","journal-title":"Nitric Oxide"},{"key":"694_CR172","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/01.HYP.0000103162.76220.51","volume":"42","author":"J-C Liu","year":"2003","unstructured":"Liu J-C, Chen J-J, Chan P, Cheng C-F, Cheng T-H. Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension. 2003;42:1198\u2013205.","journal-title":"Hypertension"},{"key":"694_CR173","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circul Res. 2016;118:1021\u201340.","journal-title":"Circul Res"},{"key":"694_CR174","doi-asserted-by":"crossref","unstructured":"Zhang Y, Lu Y, Ong\u2019achwa MJ, Ge L, Qian Y, Chen L et al. Resveratrol inhibits the TGF-\u03b21-induced proliferation of cardiac fibroblasts and collagen secretion by downregulating miR-17 in rat. BioMed research international. 2018;2018.","DOI":"10.1155\/2018\/8730593"},{"key":"694_CR175","doi-asserted-by":"publisher","first-page":"109227","DOI":"10.1016\/j.biopha.2019.109227","volume":"118","author":"Z-H Liu","year":"2019","unstructured":"Liu Z-H, Zhang Y, Wang X, Fan X-F, Zhang Y, Li X, et al. SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition. Biomed Pharmacother. 2019;118:109227.","journal-title":"Biomed Pharmacother"},{"key":"694_CR176","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","volume":"114","author":"P Libby","year":"2014","unstructured":"Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circul Res. 2014;114:1867\u201379.","journal-title":"Circul Res"},{"key":"694_CR177","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circul Res. 2016;118:535\u201346.","journal-title":"Circul Res"},{"key":"694_CR178","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr, Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circul Res. 2016;118:620\u201336.","journal-title":"Circul Res"},{"key":"694_CR179","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.niox.2011.12.006","volume":"26","author":"H Li","year":"2012","unstructured":"Li H, Xia N, F\u00f6rstermann U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide. 2012;26:102\u201310.","journal-title":"Nitric Oxide"},{"key":"694_CR180","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.niox.2006.03.011","volume":"15","author":"C Napoli","year":"2006","unstructured":"Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ. Nitric oxide and atherosclerosis: an update. Nitric Oxide. 2006;15:265\u201379.","journal-title":"Nitric Oxide"},{"key":"694_CR181","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1161\/CIRCULATIONAHA.112.001133","volume":"127","author":"M Margaritis","year":"2013","unstructured":"Margaritis M, Antonopoulos AS, Digby J, Lee R, Reilly S, Coutinho P, et al. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation. 2013;127:2209\u201321.","journal-title":"Circulation"},{"key":"694_CR182","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev.me.43.020192.001251","volume":"43","author":"S Parthasarathy","year":"1992","unstructured":"Parthasarathy S, Steinberg D, Witztum J. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219\u201325.","journal-title":"Annu Rev Med"},{"key":"694_CR183","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jcmm.12463","volume":"19","author":"L Xu","year":"2015","unstructured":"Xu L, Wang S, Li B, Sun A, Zou Y, Ge J. A protective role of ciglitazone in ox-LDL\u2010induced rat microvascular endothelial cells via modulating PPAR \u03b3\u2010dependent AMPK\/eNOS pathway. J Cell Mol Med. 2015;19:92\u2013102.","journal-title":"J Cell Mol Med"},{"key":"694_CR184","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/bph.14801","volume":"177","author":"CK Cheng","year":"2020","unstructured":"Cheng CK, Luo J-Y, Lau CW, Chen Z-Y, Tian XY, Huang Y. Pharmacological basis and new insights of resveratrol action in the cardiovascular system. Br J Pharmacol. 2020;177:1258\u201377.","journal-title":"Br J Pharmacol"},{"key":"694_CR185","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1159\/000363026","volume":"34","author":"R Guo","year":"2014","unstructured":"Guo R, Su Y, Liu B, Li S, Zhou S, Xu Y. Resveratrol suppresses oxidised low-density lipoprotein-induced macrophage apoptosis through inhibition of intracellular reactive oxygen species generation, LOX-1, and the p38 MAPK pathway. Cell Physiol Biochem. 2014;34:603\u201316.","journal-title":"Cell Physiol Biochem"},{"key":"694_CR186","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jnutbio.2019.01.022","volume":"67","author":"J Li","year":"2019","unstructured":"Li J, Zhong Z, Yuan J, Chen X, Huang Z, Wu Z. Resveratrol improves endothelial dysfunction and attenuates atherogenesis in apolipoprotein E-deficient mice. J Nutr Biochem. 2019;67:63\u201371.","journal-title":"J Nutr Biochem"},{"key":"694_CR187","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/FJC.0b013e318059ae80","volume":"50","author":"VP Ekshyyan","year":"2007","unstructured":"Ekshyyan VP, Hebert VY, Khandelwal A, Dugas TR. Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production. J Cardiovasc Pharmacol. 2007;50:83\u201393.","journal-title":"J Cardiovasc Pharmacol"},{"key":"694_CR188","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.jhh.1000949","volume":"14","author":"WB Kannel","year":"2000","unstructured":"Kannel WB. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens. 2000;14:83\u201390.","journal-title":"J Hum Hypertens"},{"key":"694_CR189","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217\u201323.","journal-title":"Lancet"},{"key":"694_CR190","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"P Rajendran","year":"2013","unstructured":"Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9:1057.","journal-title":"Int J Biol Sci"},{"key":"694_CR191","doi-asserted-by":"publisher","first-page":"F542","DOI":"10.1152\/ajprenal.00437.2013","volume":"306","author":"KL Gordish","year":"2014","unstructured":"Gordish KL, Beierwaltes WH. Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging. Am J Physiology-Renal Physiol. 2014;306:F542\u201350.","journal-title":"Am J Physiology-Renal Physiol"},{"key":"694_CR192","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","volume":"20","author":"S Wei","year":"2020","unstructured":"Wei S, Ma W, Li X, Jiang C, Sun T, Li Y, et al. Involvement of ROS\/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity. Cardiovasc Toxicol. 2020;20:507\u201319.","journal-title":"Cardiovasc Toxicol"},{"key":"694_CR193","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21037\/atm.2017.06.27","volume":"5","author":"D Moris","year":"2017","unstructured":"Moris D, Spartalis M, Spartalis E, Karachaliou GS, Karaolanis GI, Tsourouflis G, et al. The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox. Ann Transl Med. 2017;5:326.","journal-title":"Ann Transl Med"},{"key":"694_CR194","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jacc.2017.05.035","volume":"70","author":"T Munzel","year":"2017","unstructured":"Munzel T, Camici GG, Maack C, Bonetti NR, Fuster V, Kovacic JC. Impact of oxidative stress on the heart and vasculature: part 2 of a 3-Part series. J Am Coll Cardiol. 2017;70:212\u201329.","journal-title":"J Am Coll Cardiol"},{"key":"694_CR195","doi-asserted-by":"publisher","first-page":"5732956","DOI":"10.1155\/2020\/5732956","volume":"2020","author":"R D\u2019Oria","year":"2020","unstructured":"D\u2019Oria R, Schipani R, Leonardini A, Natalicchio A, Perrini S, Cignarelli A, et al. The role of oxidative stress in Cardiac Disease: from physiological response to Injury factor. Oxid Med Cell Longev. 2020;2020:5732956.","journal-title":"Oxid Med Cell Longev"},{"key":"694_CR196","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.bbadis.2013.05.018","volume":"1832","author":"VW Dolinsky","year":"2013","unstructured":"Dolinsky VW, Chakrabarti S, Pereira TJ, Oka T, Levasseur J, Beker D, et al. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochim et Biophys Acta (BBA) - Mol Basis Disease. 2013;1832:1723\u201333.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Basis Disease"},{"key":"694_CR197","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.2174\/1381612826666200909125354","volume":"27","author":"C Houacine","year":"2021","unstructured":"Houacine C, Khan I, Yousaf SS. Potential cardio-protective agents: a resveratrol review (2000\u20132019). Curr Pharm Design. 2021;27:2943\u201355.","journal-title":"Curr Pharm Design"},{"key":"694_CR198","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/01.HYP.0000159760.88697.1e","volume":"45","author":"M Herrera","year":"2005","unstructured":"Herrera M, Garvin JL. Recent advances in the regulation of nitric oxide in the kidney. Hypertension. 2005;45:1062\u20137.","journal-title":"Hypertension"},{"key":"694_CR199","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1161\/HYPERTENSIONAHA.112.199216","volume":"60","author":"NJ Hong","year":"2012","unstructured":"Hong NJ, Garvin JL, Angiotensin II. Type 2 receptor\u2013mediated inhibition of NaCl absorption is blunted in Thick Ascending limbs from Dahl Salt-Sensitive rats. Hypertension. 2012;60:765\u20139.","journal-title":"Hypertension"},{"key":"694_CR200","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejphar.2012.03.040","volume":"685","author":"JF Pad\u00edn","year":"2012","unstructured":"Pad\u00edn JF, de Diego AM, Fern\u00e1ndez-Morales JC, Merino C, Maroto M, Calvo-Gallardo E, et al. Resveratrol augments nitric oxide generation and causes store calcium release in chromaffin cells. Eur J Pharmacol. 2012;685:99\u2013107.","journal-title":"Eur J Pharmacol"},{"key":"694_CR201","doi-asserted-by":"publisher","first-page":"e110487","DOI":"10.1371\/journal.pone.0110487","volume":"9","author":"A Gonzalez-Vicente","year":"2014","unstructured":"Gonzalez-Vicente A, Cabral PD, Garvin JL. Resveratrol increases nitric oxide production in the Rat Thick Ascending Limb via Ca2+\/Calmodulin. PLoS ONE. 2014;9:e110487.","journal-title":"PLoS ONE"},{"key":"694_CR202","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2174\/138161212799436467","volume":"18","author":"A Durante","year":"2012","unstructured":"Durante A, Peretto G, Laricchia A, Ancona F, Spartera M, Mangieri A, et al. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr Pharm Design. 2012;18:981\u20131004.","journal-title":"Curr Pharm Design"},{"key":"694_CR203","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.phrs.2016.07.025","volume":"111","author":"T Qaradakhi","year":"2016","unstructured":"Qaradakhi T, Apostolopoulos V, Zulli A. Angiotensin (1\u20137) and alamandine: similarities and differences. Pharmacol Res. 2016;111:820\u20136.","journal-title":"Pharmacol Res"},{"key":"694_CR204","doi-asserted-by":"publisher","first-page":"lb559","DOI":"10.1096\/fasebj.24.1_supplement.lb559","volume":"24","author":"SR Bhatt","year":"2010","unstructured":"Bhatt SR, Lokhandwala MF, Banday AA. Resveratrol Via nitric oxide attenuates Angiotensin II Induced Acute increase in blood pressure in Sprague Dawley rats. FASEB J. 2010;24:lb559\u2013lb.","journal-title":"FASEB J"},{"key":"694_CR205","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.3390\/ijms20205034","volume":"20","author":"ROS Soares","year":"2019","unstructured":"Soares ROS, Losada DM, Jordani MC, \u00c9vora P, Castro-e-Silva O. Ischemia\/Reperfusion Injury Revisited: an overview of the latest pharmacological strategies. Int J Mol Sci. 2019;20:5034.","journal-title":"Int J Mol Sci"},{"key":"694_CR206","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.amjcard.2010.03.032","volume":"106","author":"AT Turer","year":"2010","unstructured":"Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106:360\u20138.","journal-title":"Am J Cardiol"},{"key":"694_CR207","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jicc.2017.06.017","volume":"7","author":"VK Vishwakarma","year":"2017","unstructured":"Vishwakarma VK, Upadhyay PK, Gupta JK, Yadav HN. Pathophysiologic role of ischemia reperfusion injury: a review. J Indian Coll Cardiol. 2017;7:97\u2013104.","journal-title":"J Indian Coll Cardiol"},{"key":"694_CR208","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20:1126\u201367.","journal-title":"Antioxid Redox Signal"},{"key":"694_CR209","doi-asserted-by":"publisher","first-page":"110525","DOI":"10.1016\/j.biopha.2020.110525","volume":"130","author":"A Xu","year":"2020","unstructured":"Xu A, Deng F, Chen Y, Kong Y, Pan L, Liao Q, et al. NF-kappaB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity. Biomed Pharmacother. 2020;130:110525.","journal-title":"Biomed Pharmacother"},{"key":"694_CR210","doi-asserted-by":"publisher","first-page":"112422","DOI":"10.1016\/j.biopha.2021.112422","volume":"145","author":"KM Oliveira-Costa","year":"2022","unstructured":"Oliveira-Costa KM, Menezes GB, Paula Neto HA. Neutrophil accumulation within tissues: a damage x healing dichotomy. Biomed Pharmacother. 2022;145:112422.","journal-title":"Biomed Pharmacother"},{"key":"694_CR211","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.12659\/MSM.911641","volume":"24","author":"H-H Wu","year":"2018","unstructured":"Wu H-H, Huang C-C, Chang C-P, Lin M-T, Niu K-C, Tian Y-F. Heat shock protein 70 (HSP70) reduces hepatic inflammatory and oxidative damage in a rat model of liver ischemia\/reperfusion injury with hyperbaric oxygen preconditioning. Med Sci Monitor: Int Med J Experimental Clin Res. 2018;24:8096.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"694_CR212","doi-asserted-by":"crossref","unstructured":"Nastos C, Kalimeris K, Papoutsidakis N, Tasoulis M-K, Lykoudis PM, Theodoraki K et al. Global consequences of liver ischemia\/reperfusion injury. Oxidative medicine and cellular longevity. 2014;2014.","DOI":"10.1155\/2014\/906965"},{"key":"694_CR213","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.yjmcc.2011.07.023","volume":"51","author":"JJ Lugus","year":"2011","unstructured":"Lugus JJ, Ngoh GA, Bachschmid MM, Walsh K. Mitofusins are required for angiogenic function and modulate different signaling pathways in cultured endothelial cells. J Mol Cell Cardiol. 2011;51:885\u201393.","journal-title":"J Mol Cell Cardiol"},{"key":"694_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-018-0683-0","volume":"113","author":"W Nuntaphum","year":"2018","unstructured":"Nuntaphum W, Pongkan W, Wongjaikam S, Thummasorn S, Tanajak P, Khamseekaew J, et al. Vagus nerve stimulation exerts cardioprotection against myocardial ischemia\/reperfusion injury predominantly through its efferent vagal fibers. Basic Res Cardiol. 2018;113:1\u201320.","journal-title":"Basic Res Cardiol"},{"key":"694_CR215","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2016.02.017","volume":"94","author":"J-B Park","year":"2016","unstructured":"Park J-B, Nagar H, Choi S, Jung S-b, Kim H-W, Kang SK, et al. IDH2 deficiency impairs mitochondrial function in endothelial cells and endothelium-dependent vasomotor function. Free Radic Biol Med. 2016;94:36\u201346.","journal-title":"Free Radic Biol Med"},{"key":"694_CR216","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10456-020-09720-2","volume":"23","author":"J Wang","year":"2020","unstructured":"Wang J, Toan S, Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia\/reperfusion injury. Angiogenesis. 2020;23:299\u2013314.","journal-title":"Angiogenesis"},{"key":"694_CR217","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5114\/fn.2012.30522","volume":"50","author":"H Pradeep","year":"2012","unstructured":"Pradeep H, Diya JB, Shashikumar S, Rajanikant GK. Oxidative stress\u2013assassin behind the ischemic stroke. Folia Neuropathol. 2012;50:219\u201330.","journal-title":"Folia Neuropathol"},{"key":"694_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-9-211","volume":"9","author":"L Zhang","year":"2012","unstructured":"Zhang L, Dong L-Y, Li Y-J, Hong Z, Wei W-S. The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor. J Neuroinflamm. 2012;9:1\u201312.","journal-title":"J Neuroinflamm"},{"key":"694_CR219","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.freeradbiomed.2011.08.034","volume":"51","author":"MA Robinson","year":"2011","unstructured":"Robinson MA, Baumgardner JE, Otto CM. Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase. Free Radic Biol Med. 2011;51:1952\u201365.","journal-title":"Free Radic Biol Med"},{"key":"694_CR220","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.expneurol.2007.12.003","volume":"210","author":"A Lu","year":"2008","unstructured":"Lu A, Clark JF, Broderick JP, Pyne-Geithman GJ, Wagner KR, Ran R, et al. Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol. 2008;210:549\u201359.","journal-title":"Exp Neurol"},{"key":"694_CR221","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/nu11010105","volume":"11","author":"N Fourny","year":"2019","unstructured":"Fourny N, Lan C, S\u00e9r\u00e9e E, Bernard M, Desrois M. Protective effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 expression in type 2 Diabetic Female Rat Heart. Nutrients. 2019;11:105.","journal-title":"Nutrients"},{"key":"694_CR222","first-page":"1120","volume":"11","author":"J Li","year":"2015","unstructured":"Li J, Xie C, Zhuang J, Li H, Yao Y, Shao C, et al. Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion: role of the TLR4\/NF-\u03baB signaling pathway. Mol Med Rep. 2015;11:1120\u20136.","journal-title":"Mol Med Rep"},{"key":"694_CR223","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1097\/CCM.0b013e3181782335","volume":"36","author":"J Li","year":"2008","unstructured":"Li J, Zhang H, Wu F, Nan Y, Ma H, Guo W, et al. Insulin inhibits tumor necrosis factor-\u03b1 induction in myocardial ischemia\/reperfusion: role of akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med. 2008;36:1551\u20138.","journal-title":"Crit Care Med"},{"key":"694_CR224","first-page":"179","volume":"77","author":"H Cui","year":"2022","unstructured":"Cui H, Yang Y, Li X, Zong W, Li Q. Resveratrol regulates paracrine function of cardiac microvascular endothelial cells under hypoxia\/reoxygenation condition. Die Pharmazie-An Int J Pharm Sci. 2022;77:179\u201385.","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"key":"694_CR225","doi-asserted-by":"publisher","first-page":"105725","DOI":"10.1016\/j.phrs.2021.105725","volume":"170","author":"N Parsamanesh","year":"2021","unstructured":"Parsamanesh N, Asghari A, Sardari S, Tasbandi A, Jamialahmadi T, Xu S, et al. Resveratrol and endothelial function: a literature review. Pharmacol Res. 2021;170:105725.","journal-title":"Pharmacol Res"},{"key":"694_CR226","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jvs.2007.04.044","volume":"46","author":"S-K Tsai","year":"2007","unstructured":"Tsai S-K, Hung L-M, Fu Y-T, Cheng H, Nien M-W, Liu H-Y, et al. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg. 2007;46:346\u201353.","journal-title":"J Vasc Surg"},{"key":"694_CR227","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015;89:1401\u201338.","journal-title":"Arch Toxicol"},{"key":"694_CR228","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1172\/JCI25397","volume":"116","author":"C Perrino","year":"2006","unstructured":"Perrino C, Prasad SVN, Mao L, Noma T, Yan Z, Kim H-S, et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Investig. 2006;116:1547\u201360.","journal-title":"J Clin Investig"},{"key":"694_CR229","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010;128:191\u2013227.","journal-title":"Pharmacol Ther"},{"key":"694_CR230","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Reviews Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Reviews Cardiol"},{"key":"694_CR231","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41392-023-01652-9","volume":"8","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Xiong W, Li C, Zhao R, Lu H, Song S, et al. Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. Signal Transduct Target Ther. 2023;8:431.","journal-title":"Signal Transduct Target Ther"},{"key":"694_CR232","doi-asserted-by":"publisher","first-page":"6819281","DOI":"10.1155\/2017\/6819281","volume":"2017","author":"A Riba","year":"2017","unstructured":"Riba A, Deres L, Sumegi B, Toth K, Szabados E, Halmosi R. Cardioprotective effect of Resveratrol in a Postinfarction Heart failure model. Oxidative Med Cell Longev. 2017;2017:6819281.","journal-title":"Oxidative Med Cell Longev"},{"key":"694_CR233","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.cardiores.2005.01.021","volume":"66","author":"H Ruetten","year":"2005","unstructured":"Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovascular Res. 2005;66:444\u201353.","journal-title":"Cardiovascular Res"},{"key":"694_CR234","doi-asserted-by":"publisher","first-page":"27452","DOI":"10.1074\/jbc.M802578200","volume":"283","author":"J Zhang","year":"2008","unstructured":"Zhang J, Xie Z, Dong Y, Wang S, Liu C, Zou M-H. Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells. J Biol Chem. 2008;283:27452\u201361.","journal-title":"J Biol Chem"},{"key":"694_CR235","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1124\/mol.109.058479","volume":"76","author":"SM Shin","year":"2009","unstructured":"Shin SM, Cho IJ, Kim SG. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3\u03b2 inhibition downstream of poly (ADP-ribose) polymerase-LKB1 pathway. Mol Pharmacol. 2009;76:884\u201395.","journal-title":"Mol Pharmacol"},{"key":"694_CR236","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejphar.2011.06.042","volume":"668","author":"SJ Thandapilly","year":"2011","unstructured":"Thandapilly SJ, Louis XL, Yang T, Stringer DM, Yu L, Zhang S, et al. Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway. Eur J Pharmacol. 2011;668:217\u201324.","journal-title":"Eur J Pharmacol"},{"key":"694_CR237","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/kjm2.12199","volume":"36","author":"CW Wu","year":"2020","unstructured":"Wu CW, Nakamoto Y, Hisatome T, Yoshida S, Miyazaki H. Resveratrol and its dimers \u03b5-viniferin and \u03b4-viniferin in red wine protect vascular endothelial cells by a similar mechanism with different potency and efficacy. Kaohsiung J Med Sci. 2020;36:535\u201342.","journal-title":"Kaohsiung J Med Sci"},{"key":"694_CR238","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1152\/japplphysiol.00686.2017","volume":"125","author":"T-C Yeh","year":"2018","unstructured":"Yeh T-C, Shin C-S, Chen H-H, Lai C-C, Sun G-C, Tseng C-J, et al. Resveratrol regulates blood pressure by enhancing AMPK signaling to downregulate a Rac1-derived NADPH oxidase in the central nervous system. J Appl Physiol. 2018;125:40\u20138.","journal-title":"J Appl Physiol"},{"key":"694_CR239","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3390\/ijms19082459","volume":"19","author":"C-N Hsu","year":"2018","unstructured":"Hsu C-N, Lin Y-J, Lu P-C, Tain Y-L. Maternal resveratrol therapy protects male rat offspring against programmed Hypertension Induced by TCDD and Dexamethasone exposures: is it relevant to Aryl Hydrocarbon receptor? Int J Mol Sci. 2018;19:2459.","journal-title":"Int J Mol Sci"},{"key":"694_CR240","doi-asserted-by":"publisher","first-page":"108630","DOI":"10.1016\/j.jnutbio.2021.108630","volume":"93","author":"C-N Hsu","year":"2021","unstructured":"Hsu C-N, Hou C-Y, Chang-Chien G-P, Lin S, Chan JYH, Lee C-T, et al. Maternal resveratrol therapy protected adult rat offspring against hypertension programmed by combined exposures to asymmetric dimethylarginine and trimethylamine-N-oxide. J Nutr Biochem. 2021;93:108630.","journal-title":"J Nutr Biochem"},{"key":"694_CR241","doi-asserted-by":"publisher","first-page":"4154010","DOI":"10.1155\/2020\/4154010","volume":"2020","author":"X Jia","year":"2020","unstructured":"Jia X, Zhang R, Guo J, Yue H, Liu Q, Guo L, et al. Resveratrol Supplementation prevents hypertension in hypertensive pregnant rats by increasing Sodium Excretion and serum nitric oxide level. Int J Hypertens. 2020;2020:4154010.","journal-title":"Int J Hypertens"},{"key":"694_CR242","doi-asserted-by":"publisher","first-page":"110659","DOI":"10.1016\/j.biopha.2020.110659","volume":"131","author":"S Viana-Mattioli","year":"2020","unstructured":"Viana-Mattioli S, Cinegaglia N, Bertozzi-Matheus M, Bueno-Pereira TO, Caldeira-Dias M, Cavalli RC, et al. SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia. Biomed Pharmacother. 2020;131:110659.","journal-title":"Biomed Pharmacother"},{"key":"694_CR243","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00210-022-02264-w","volume":"395","author":"HA Ebrahim","year":"2022","unstructured":"Ebrahim HA, Kamar SS, Haidara MA, Latif NSA, Ellatif MA, ShamsEldeen AM, et al. Association of resveratrol with the suppression of TNF-\u03b1\/NF-kB\/iNOS\/HIF-1\u03b1 axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury. Naunyn Schmiedebergs Arch Pharmacol. 2022;395:1087\u201395.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"694_CR244","doi-asserted-by":"crossref","unstructured":"Zhang L, Chen J, Yan L, He Q, Xie H, Chen M. Resveratrol ameliorates Cardiac Remodeling in a murine model of heart failure with preserved ejection fraction. Front Pharmacol. 2021;12.","DOI":"10.3389\/fphar.2021.646240"},{"key":"694_CR245","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/10715762.2018.1554901","volume":"53","author":"L Feng","year":"2019","unstructured":"Feng L, Ren J, Li Y, Yang G, Kang L, Zhang S, et al. Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B\/AMPK\/eNOS\/NO signalling pathway. Free Radic Res. 2019;53:82\u201393.","journal-title":"Free Radic Res"},{"key":"694_CR246","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2174\/0929867327666200130104757","volume":"28","author":"AR Afshari","year":"2021","unstructured":"Afshari AR, Mollazadeh H, Mohtashami E, Soltani A, Soukhtanloo M, Hosseini A, et al. Protective role of natural products in glioblastoma multiforme: a focus on nitric oxide pathway. Curr Med Chem. 2021;28:377\u2013400.","journal-title":"Curr Med Chem"},{"key":"694_CR247","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ddr.22051","volume":"84","author":"J Zhu","year":"2023","unstructured":"Zhu J, Jiang X, Luo X, Zhao R, Li J, Cai H, et al. Combination of chemotherapy and gaseous signaling molecular therapy: novel beta-elemene nitric oxide donor derivatives against leukemia. Drug Dev Res. 2023;84:718\u201335.","journal-title":"Drug Dev Res"},{"key":"694_CR248","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.niox.2023.12.003","volume":"143","author":"S Abolfazli","year":"2024","unstructured":"Abolfazli S, Mortazavi P, Kheirandish A, Butler AE, Jamialahmadi T, Sahebkar A. Regulatory effects of curcumin on nitric oxide signaling in the cardiovascular system. Nitric Oxide - Biology Chem. 2024;143:16\u201328.","journal-title":"Nitric Oxide - Biology Chem"},{"key":"694_CR249","doi-asserted-by":"crossref","unstructured":"Martellet MC, Martins A, Marmitt DJ, Schneider T, Contini V, Goettert MI. Chapter 1 - new opportunities for the application of natural products based on nitric oxide modulation: from research to registered patents. In: Atta ur R, editor. Studies in Natural products Chemistry. Elsevier; 2020. pp. 1\u201340.","DOI":"10.1016\/B978-0-12-817905-5.00001-9"},{"key":"694_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2022.11.001","volume":"130","author":"T Behl","year":"2023","unstructured":"Behl T, Rana T, Sehgal A, Makeen HA, Albratty M, Alhazmi HA, et al. Phytochemicals targeting nitric oxide signaling in neurodegenerative diseases. Nitric Oxide. 2023;130:1\u201311.","journal-title":"Nitric Oxide"},{"key":"694_CR251","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/nure.12081","volume":"71","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A. Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2013;71:822\u201335.","journal-title":"Nutr Rev"},{"key":"694_CR252","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2015.04.008","volume":"189","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban C, Ursoniu S, Wong ND, Muntner P, Graham IM, et al. Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors\u2013results from a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2015;189:47\u201355.","journal-title":"Int J Cardiol"},{"key":"694_CR253","doi-asserted-by":"crossref","unstructured":"Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol. 2017;1.","DOI":"10.1038\/s41698-017-0038-6"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00694-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00694-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00694-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:00:03Z","timestamp":1742216403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00694-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":253,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00694-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}